FlaggedRx · Recall check

Nitrosamine (NDMA / NDEA) recalls

455 matching FDA recall record(s) · checked Jul 06, 2026

Public FDA recall information, not medical advice. These are records whose FDA-stated reason matches this cause — not an exhaustive taxonomy, and a drug absent here has not been cleared. Never stop a prescribed medicine without asking your pharmacist or doctor.

What this means

Nitrosamines — NDMA, NDEA, and NMBA — are probable human carcinogens that can form during drug manufacturing or over time in storage. Since 2018 they have driven some of the largest drug recalls on record, starting with the “sartan” blood-pressure drugs (valsartan, losartan, irbesartan), then ranitidine (Zantac), then extended-release metformin. The impurity usually traced back to the active ingredient made at overseas facilities.

Recalls with this cause

By cause

Nitrosamine (NDMA / NDEA) recallsMicrobial contamination recallsParticulate matter / glass recallsSterility failure recallsLabeling & mix-up recallsCheck a drug →